Onset of vitiligo in a patient with acquired secondary hypogonadism under treatment with testosterone gel 2%: inside the pathogenesis
An Bras Dermatol
.
2020 Sep-Oct;95(5):661-662.
doi: 10.1016/j.abd.2020.02.010.
Epub 2020 Jul 15.
Authors
Giovanni Paolino
1
,
Pietro Bearzi
2
,
Santo Raffaele Mercuri
1
Affiliations
1
Department of Dermatology, IRCCS Ospedale San Raffaele, Milan, Italy.
2
Department of Dermatology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: pietro.bearzi@gmail.com.
PMID:
32713727
PMCID:
PMC7563011
DOI:
10.1016/j.abd.2020.02.010
No abstract available
Publication types
Case Reports
MeSH terms
Hormone Replacement Therapy
Humans
Hypogonadism* / chemically induced
Hypogonadism* / drug therapy
Hypopigmentation*
Testosterone / adverse effects
Vitiligo* / chemically induced
Substances
Testosterone